Vepdegestrant, a PROTAC estrogen receptor degrader, in advanced breast cancer
In this latest episode of the VJOncoAlert Journal Club, Erika Hamilton, MD, Sarah Cannon Cancer Center, Nashville, TN, discusses the findings of the VERITAC-2 trial (NCT05654623), a Phase III, open-labeled, randomized trial evaluating vepdegestrant, an oral proteolysis-targeting chimera (PROTAC) estrogen receptor (ER) degrader, in patients with ER-positive, HER2-negative advanced breast cancer, as published in the New England Journal of Medicine (NEJM). In the VERITAC-2 trial, vepdegestrant significantly improved progression-free survival versus fulvestrant in ESR1-mutated advanced breast cancer patients previously treated with endocrine therapy and CDK4/6 inhibitors. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Selective Estrogen Receptor Degraders (SERDs) in Hormone Receptor Positive Breast Cancer

The Importance of Oncodermatology: Advancing Skincare for Cancer Patients

Hormone Receptors in Breast Cancer: ER, PR, and HR Explained

Before you Start or Refuse Cancer Therapy- WATCH THIS!

I Swapped Diets With A Victoria's Secret Model

We Bought Temu's Craziest Product!!!

Vepdegestrant Mechanism of Action: The First PROTAC for Breast Cancer Explained

When Is A Retiree ACTUALLY Considered Wealthy?

Why Is Treatment SO LONG? Tamoxifen & Aromatase Inhibitors for HR+ Breast Cancer
![Your Phone Is Destroying Your Sense of Meaning | Arthur Brooks [ARC 2026]](https://i.ytimg.com/vi/PfTcgYwW14E/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLBzBqlOzXKaS_MJrH8pIKehA8ZKPQ)
Your Phone Is Destroying Your Sense of Meaning | Arthur Brooks [ARC 2026]

He Died in His Sleep Because of THIS — Doctor Explains the Silent Killer

Nervous System Regulation (999 Hz) | 1 hour handpan music | Malte Marten

She’s 12. She Sings Aretha Franklin… Until Simon TELLS Her to Do It Acapella! 😳

91 Year-Old Grandmother Living Alone In A Mountain Village Forgotten By The World

This Has Just Become the Most Powerful Breakfast Food

Bryn Taylor: Understanding the Chameleonicity and Permeability of PROTACs
![Understand AI in 14 minutes – with Anthropic's Chloe Lubinski [ARC 2026]](https://i.ytimg.com/vi/aBUniZHgCnE/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLCyQJdkwlip_867U0IUOY4wCWZJ0g)
Understand AI in 14 minutes – with Anthropic's Chloe Lubinski [ARC 2026]

Why Can Cancer Return YEARS Later?

Vepdegestrant + palbociclib in ER+ metastatic breast cancer: Phase Ib trial results

